Lung Cancer Resource Center

Cardiac Injury and Death in COVID-19 Patients from Wuhan, China

Hospital in Wuhan, China Says Patients with Cancer are More Susceptible to COVID-19

Patients with cancer have a higher risk of COVID-19 infection compared with the general public, according to a research letter published in JAMA Oncology...
Lung Cancer Therapy May Enhance Metastatic Brain Cancer Outcomes

Lung Cancer Therapy May Enhance Metastatic Brain Cancer Outcomes

A medication commonly used to treat non-small cell lung cancer that has spread may offer benefits for patients with metastatic brain cancers, according to...
Black and Hispanic Patients Less Likely to Receive PET/CT Imaging for Lung Cancer—Does This Affect Survival?

Black and Hispanic Patients Less Likely to Receive PET/CT Imaging for Lung Cancer—Does This...

According to a new report, black and Hispanic patients are less likely to undergo recommended PET/CT imaging upon lung cancer diagnosis, possibly impacting survival...
lung, Study: Smoking Cessation Prior to Lung Cancer Surgery Is Beneficial

Despite USPSTF Recommendations, Seven in Eight High-Risk Lung Cancer Patients Do Not Receive Screenings

Current and former smokers have an increased risk for developing lung cancer compared to the general population. For this reason, the U.S. Preventive Services...
Agricultural area residents in danger of inhaling toxic aerosols

Agricultural Area Residents in Danger of Inhaling Toxic, Lung Cancer-Causing Aerosols

According to the findings of a study published in the journal Environmental Science & Technology excess selenium from fertilizers and other natural sources can...
PDA, Artificial Intelligence Detects Signs of Heart Disease on Lung Cancer Screenings

Patient Decision Aid for Lung Cancer Screening in Smokers: Is It Effective?

A randomized, clinical study compared the efficacy of a patient decision aid (PDA) about lung cancer screening versus a standard educational material (EDU) regarding...
Life-Gained-Based Selection Could Maximize the Benefits of Lung Cancer Screening

Novel Agent Tislelizumab Extends Survival in Lung Cancer: Interim Phase III Report

The novel agent tislelizumab improved progression-free survival (PFS; primary endpoint) in the firstline setting in patients with squamous non-small cell lung cancer (NSCLC), according...

Curated Journal Reading List